Literature DB >> 15225657

ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Mitchell B Berger1, Jeannine M Mendrola, Mark A Lemmon.   

Abstract

To understand signaling by the neuregulin (NRG) receptor ErbB3/HER3, it is important to know whether ErbB3 forms homodimers upon ligand binding. Previous biophysical studies suggest that the ErbB3 extracellular region remains monomeric when bound to NRG. We used a chimeric receptor approach to address this question in living cells, fusing the extracellular region of ErbB3 to the kinase-active intracellular domain of ErbB1. The ErbB3/ErbB1 chimera responded to NRG only if ErbB2 was co-expressed in the same cells, whereas an ErbB4/ErbB1 chimera responded without ErbB2. We, therefore, suggest that ErbB3 is an obligate heterodimerization partner because of its inability to homodimerize.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225657     DOI: 10.1016/j.febslet.2004.06.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  67 in total

1.  ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Authors:  J Spencer Liles; Juan Pablo Arnoletti; Ching-Wei D Tzeng; J Harrison Howard; Andrew V Kossenkov; Peter Kulesza; Martin J Heslin; Andrey Frolov
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

2.  A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions.

Authors:  T S Wehrman; W J Raab; C L Casipit; R Doyonnas; J H Pomerantz; H M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

Review 3.  Host cell manipulation by the human pathogen Toxoplasma gondii.

Authors:  J Laliberté; V B Carruthers
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

4.  erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.

Authors:  Mara P Steinkamp; Shalini T Low-Nam; Shujie Yang; Keith A Lidke; Diane S Lidke; Bridget S Wilson
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

5.  Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Authors:  Jessica P Dawson; Mitchell B Berger; Chun-Chi Lin; Joseph Schlessinger; Mark A Lemmon; Kathryn M Ferguson
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.

Authors:  Natalia Jura; Yibing Shan; Xiaoxian Cao; David E Shaw; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 7.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

8.  Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.

Authors:  Tracy E Strecker; Qiang Shen; Yun Zhang; Jamal L Hill; Yuxin Li; Chunyu Wang; Hee-Tae Kim; Tona M Gilmer; Krystal R Sexton; Susan G Hilsenbeck; C Kent Osborne; Powel H Brown
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

Review 9.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

10.  Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response.

Authors:  Harish Shankaran; H Steven Wiley; Haluk Resat
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.